Flake Graphene-Based Nanomaterial Approach for Triggering a Ferroptosis as an Attractive Theranostic Outlook for

Joanna Pancewicz1, Wiesława Ewa Niklińska1, Adrian Chlanda2

  • 1Department of Histology and Embryology, Medical University in Bialystok, Waszyngtona 13, 15-269 Białystok, Poland.

Insights

Researchers explored ferroptosis, an iron-related cell death, and graphene nanomaterials for treating lung cancer. This approach offers a new strategy beyond apoptosis for cancer therapy.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Materials Science

Background:

  • Lung cancer is a leading cause of cancer death globally.
  • Current anti-cancer drugs primarily induce apoptosis, but their efficiency is often limited.
  • Alternative programmed cell death pathways are needed to overcome therapeutic resistance.

Purpose of the Study:

  • To review the emerging cell death pathway, ferroptosis, in the context of non-small lung cancer.
  • To explore the potential of graphene-based nanomaterials in cancer therapy.
  • To bridge the understanding between ferroptosis and graphene's biological applications.

Main Methods:

  • Literature review on non-small lung cancer biology.
  • Review of ferroptosis mechanisms and characteristics.
  • Analysis of graphene-based nanomaterials and their properties.

Main Results:

  • Ferroptosis is a distinct programmed cell death characterized by iron accumulation.
  • Graphene nanomaterials possess unique properties relevant to biological applications.
  • The combination of ferroptosis and graphene offers a novel therapeutic avenue.

Conclusions:

  • Ferroptosis presents a promising alternative to apoptosis for lung cancer treatment.
  • Graphene nanomaterials show potential for targeted drug delivery and therapy enhancement.
  • Further research into ferroptosis-inducing graphene-based strategies is warranted for lung cancer.

Related Concept Videos